A study in Lancet Global Health led by UNC School of Medicine’s Peyton Thompson, MD, MSCR and Jonathan Parr, MD, MPH showed the feasibility and acceptance of hepatitis B virus testing, treatment, and vaccination programs in the Democratic Republic of the Congo.